The publications on this site are part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Informa
Skip to Page Content

Full Deal Summary

Mochida Pharmaceutical Co. Ltd. granted Amarin Corp. PLC exclusive rights to certain intellectual property for use in developing and commercializing products in the US and certain other territories.

The IP is based on the omega-3 acid eicosapentaenoic acid (EPA). Mochida and Amarin are both specializing in the development of EPA therapies for patients at risk for cardiovascular disease. Amarin successfully developed and currently markets Vascepa (icosapent ethyl), the only FDA-approved prescription pure EPA drug. Vascepa is sold as an adjunct to diet for reducing triglyceride levels in adults with hypertriglyceridemia. Amarin is conducting the REDUCE-IT cardiovascular outcomes study for the drug and anticipates top-line data before the end of Q3 2018.


+ Show All | – Hide All

Financials

There are no financials available.

Deal Information


Click a keyword for comparable deals.

Deal Industry Biotechnology
Pharmaceuticals
Deal Status Final
Deal Type Alliance
R+D and Marketing-Licensing
Latest Phase at Time of Deal Research
Discovery

Product Information


Click a keyword for comparable deals.

Product 1 of 2
Product Type Pharmaceutical
Generic Name Eicosapentaenoic acid
Highest Phase at Time of Deal Research
Discovery
Product Therapeutic Area(s) of Focus Cardiovascular
Clinical Developer Amarin Corp. PLC

Product 2 of 2
Product Type Technology
Product Therapeutic Area(s) of Focus Cardiovascular
Licenser Name Mochida Pharmaceutical Co. Ltd.
Licensee Name Amarin Corp. PLC
Carveouts for Amarin Corp. PLC
Territories Licensed Worldwide
North America
Worldwide/North America/USA (Exclusive)

Company Information


Click a keyword for comparable companies.

Amarin Corp. PLC www.amarincorp.com | Ticker: AMRN
View Company Profile | View Company Deals
Company Location Worldwide
Europe
Western Europe
Ireland
Industry Biotechnology
Pharmaceuticals
Ownership Public
Therapeutic Area(s) of Focus Cardiovascular
Alias(es) Ethical Holdings

Mochida Pharmaceutical Co. Ltd. www.mochida.co.jp
View Company Profile | View Company Deals
Company Location Worldwide
Asia
Pacific Rim
Japan
Industry Medical Devices
Diagnostic Imaging Equipment & Supplies
Ultrasound
Monitoring Equipment & Devices
Pharmaceuticals
Nutraceuticals
OTC, Consumer
Ownership Public
Therapeutic Area(s) of Focus Non-Specific
Revenue $954.18mm